Germline TP53 mutational spectrum in French Canadians with breast cancer.

about

p53 deficiency induces cancer stem cell pool expansion in a mouse model of triple-negative breast tumors.

P2860

Q42500912-BE018FB8-E83C-428E-9926-5C62FBECD61D

P2860

Germline TP53 mutational spectrum in French Canadians with breast cancer.

Item

http://www.wikidata.org/entity/Q35618321

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@ast

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@en

type

Item

label

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@ast

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@en

prefLabel

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@ast

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@en

P1476

Germline TP53 mutational spectrum in French Canadians with breast cancer.

@en

P2093

Diane Provencher

http://www.w3.org/2001/XMLSchema#string

Mohammed R Akbari

http://www.w3.org/2001/XMLSchema#string

Patricia N Tonin

http://www.w3.org/2001/XMLSchema#string

Suzanna L Arcand

http://www.w3.org/2001/XMLSchema#string

P2860

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium.

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome.

Population history and its impact on medical genetics in Quebec.

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

P2888

s12881-015-0169-y

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12881-015-0169-Y

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Marie Mes-Masson

William D Foulkes

Steven A. Narod

P577

2015-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275667668

http://www.w3.org/2001/XMLSchema#string

P6179

1002555018

http://www.w3.org/2001/XMLSchema#string

P698

25925845

http://www.w3.org/2001/XMLSchema#string

P932

4436120

http://www.w3.org/2001/XMLSchema#string

Germline TP53 mutational spectrum in French Canadians with breast cancer.

about

P2860

P2860

Germline TP53 mutational spectrum in French Canadians with breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932